Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 4
1994 1
1995 1
1997 1
1998 3
1999 1
2000 5
2001 3
2002 1
2004 2
2006 4
2008 2
2009 3
2010 6
2011 9
2012 8
2013 6
2014 11
2015 10
2016 16
2017 12
2018 11
2019 8
2020 18
2021 15
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

139 results
Results by year
Filters applied: . Clear all
Page 1
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators. Pascual J, et al. Among authors: watarai y. J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11. J Am Soc Nephrol. 2018. PMID: 29752413 Free PMC article. Clinical Trial.
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study.
Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Gutierrez MPH, Marti AM, Bernhardt P, Pascual J; TRANSFORM investigators. Berger SP, et al. Among authors: watarai y. Am J Transplant. 2019 Nov;19(11):3018-3034. doi: 10.1111/ajt.15480. Epub 2019 Jul 1. Am J Transplant. 2019. PMID: 31152476 Free article. Clinical Trial.
Current problems of chronic active antibody-mediated rejection.
Takeda A, Horike K, Ohtsuka Y, Inaguma D, Goto N, Watarai Y, Uchida K, Morozumi K. Takeda A, et al. Among authors: watarai y. Clin Transplant. 2011 Jul;25 Suppl 23:2-5. doi: 10.1111/j.1399-0012.2011.01451.x. Clin Transplant. 2011. PMID: 21623906 Review.
Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients.
Pascual J, Berger SP, Chadban SJ, Citterio F, Kamar N, Hesselink DA, Legendre C, Eisenberger U, Oppenheimer F, Russ GR, Sommerer C, Rigotti P, Srinivas TR, Watarai Y, Henry ML, Vincenti F, Tedesco-Silva H. Pascual J, et al. Among authors: watarai y. Transplant Rev (Orlando). 2019 Oct;33(4):191-199. doi: 10.1016/j.trre.2019.07.001. Epub 2019 Jul 23. Transplant Rev (Orlando). 2019. PMID: 31377099 Review.
Triglyceride metabolism in Japanese kidney transplant recipients.
Tsujita M, Goto N, Futamura K, Okada M, Hiramitsu T, Narumi S, Watarai Y. Tsujita M, et al. Among authors: watarai y. Clin Exp Nephrol. 2018 Apr;22(2):459-464. doi: 10.1007/s10157-017-1462-1. Epub 2017 Aug 28. Clin Exp Nephrol. 2018. PMID: 28849320
Study of Glomerulopathy in Donors after Kidney Transplantation.
Murata M, Takeda A, Ootsuka Y, Shinjo H, Ito C, Watanabe Y, Washino M, Nakano Y, Tomosugi T, Futamura K, Okada M, Hiramitsu T, Goto N, Ichimori T, Narumi S, Watarai Y, Nishihira M, Morozumi K. Murata M, et al. Among authors: watarai y. Nephron. 2020;144 Suppl 1:86-90. doi: 10.1159/000512137. Epub 2020 Nov 30. Nephron. 2020. PMID: 33254170 Free article.
139 results